Publication

Structural strains of misfolded tau protein define different diseases

Related publications (37)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Structural strains of misfolded tau protein define different diseases

Graph Chatbot

Chat with Graph Search

Method of preparation of amyloidogenic protein aggregates and uses thereof

Deconstructing and Reconstructing the Complexity of Tau pathology

Effective Inhibition of TDP-43 Aggregation by Native State Stabilization

Trans‐seeding of Alzheimer‐related tau protein by a yeast prion

Neurodegeneration Structural strains of tau protein classify diseases

To target Tau pathologies, we must embrace and reconstruct their complexities

Rethinking protein aggregation and drug discovery in neurodegenerative diseases: Why we need to embrace complexity?

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Effects of sedimentation, microgravity, hydrodynamic mixing and air-water interface on alpha-synuclein amyloid formation